Gil Efron

Gil has served as Purple Biotech's Chief Executive Officer since July 2022. Prior to that, Mr. Efron served as the President and Chief Financial Officer from June 2021 to July 2022, and prior to that, he served as the Deputy Chief Executive Officer and Chief Financial Officer, since October 2018. Prior to joining Purple Biotech, Mr. Efron served as deputy chief executive officer and chief financial officer of Kamada Ltd., a NASDAQ and TASE dual-listed plasma-derived protein therapeutics company, from September 2011 to November 2017. Prior to that, Mr. Efron served as the chief financial officer of NASDAQ listed RRsat Global Communications Ltd. (Nasdaq: RRST), from September 2005 to March 2011. Prior to that, Mr. Efron served in various finance executive positions. Mr. Efron presently serves on the board of directors of Kanabo Group PLC (KNB:London). Mr. Efron holds a B.A. degree in Economics and Accounting and an M.A. degree in Business Administration from the Hebrew University of Jerusalem and was granted a certified public accountant’s license in Israel (which is currently inactive).